Audits and cohort studies on the adverse events of bee venom therapy

AE: adverse event; SR: systemic reaction; LR: local reaction; LLR: large local reaction; VIT: venom immunotherapy; RVIT: rush VIT; SIT: specific immunotherapy; RSIT: rush-specific immunotherapy; CVIT; cluster VIT; IP: induction phase; EP: extension phase; MP: maintenance phase.a If it was not reported in prospective articles, it was considered a retrospective study.b Venom type: bees (family Apidae); wasps (family Vespidae); single (some bee venom or some wasp venom); mix (bee and wasp venom).c Incidence: number of patients with AEs/number of patients of total cases, %d Incidence: number of cases with AEs/number of patients of total cases.e Incidence: number of injections (dose) that resulted in AEs/total number of injections (dose), % (if the number of patients with AEs was not mentioned or precisely presented).f Incidence of AEs caused by BVTs combined with the incidence of AEs from other allergens.g This study was the only report of anaphylaxis related to BVT..